Versatope Therapeutics
company
About
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
- Lowell,Massachusetts,United States
- 1 - 10
Details
- Last Funding Type
- Funding Round
- Last Funding Money Raised
- $193K
- Industries
- Biotechnology
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$18.39M
Versatope Therapeutics has raised a total of
$18.39M
in funding over 2 rounds. Their latest funding was raised on
Sep 9, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 9, 2020 | Grant | $300K | 1 | — | — | Detail |
| Sep 3, 2019 | Funding Round | $193K | — | — | — | Detail |
| Sep 26, 2018 | Grant | $17.90M | 1 | — | — | Detail |
| May 23, 2017 | Non-Equity Assistant | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Versatope Therapeutics is funded by 3 investors.
Massachusetts Life Sciences Center
and National Institute of Allergy and Infectious Diseases
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Massachusetts Life Sciences Center
|
— | Grant |
National Institute of Allergy and Infectious Diseases
|
— | Grant |
MassChallenge
|
— | Non-Equity Assistant |
Employee Profiles
Number of Employee Profiles
1
Versatope Therapeutics has 1 current employee profiles, including
Executive Christopher Locher
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
